Share this:
Published on: June 26, 2017 at 12:00PM
Conditions: Triple Negative Breast Cancer; Stage IV Breast Cancer; HER2 Negative; Invasive Breast Cancer
Interventions: Drug: Atezolizumab; Drug: Carboplatin; Other: Laboratory Biomarker; Other: Quality-of-Life Assessment
Sponsors: Vanderbilt-Ingram Cancer Center; National Cancer Institute (NCI)
Not yet recruiting – verified June 2017
http://ift.tt/2sBnLAK
More Stories
‘My 401k Misses You’: Black Woman Pumped To Meet Donald Trump In Philadelphia – July 18, 2023 at 04:56PM
Energy Provider Warns of Impending ‘Crisis,’ ‘Blackout Conditions’ Driven By Biden Plans – July 18, 2023 at 04:20PM
Dog starts barking at cows crossing a bridge, so the cows stop to have a look. – July 17, 2023 at 02:27PM